110 related articles for article (PubMed ID: 2811900)
21. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
22. [Molecular mechanisms of selecting influenza virus strains by signs of drug resistance].
Blinov VM; Resenchuk SM; Karginov VA; Mishin VP; Kozeletskaia KN; Sandakhchiev LS; Kiselev OI
Dokl Akad Nauk SSSR; 1991; 319(6):1480-4. PubMed ID: 1794277
[No Abstract] [Full Text] [Related]
23. [Comparative study of the polypeptide composition of influenza A viruses sensitive and resistant to remantadine].
L'vov ND; Vladimirtseva EA; Pushkarskaia NL; Nochemasova ZN
Vopr Virusol; 1981; (5):537-41. PubMed ID: 7336680
[TBL] [Abstract][Full Text] [Related]
24. [Effect of remantadine on the hemolytic activity of influenza virus hemagglutinin].
Gendon IuZ; Markushin SG; Mel'nikova SIa
Vopr Virusol; 1986; 31(4):414-20. PubMed ID: 3765565
[No Abstract] [Full Text] [Related]
25. Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006.
Tang JW; Ngai KL; Wong JC; Lam WY; Chan PK
J Med Virol; 2008 May; 80(5):895-901. PubMed ID: 18360910
[TBL] [Abstract][Full Text] [Related]
26. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.
Houck P; Hemphill M; LaCroix S; Hirsh D; Cox N
Arch Intern Med; 1995 Mar; 155(5):533-7. PubMed ID: 7864709
[TBL] [Abstract][Full Text] [Related]
27. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.
Hata M; Tsuzuki M; Goto Y; Kumagai N; Harada M; Hashimoto M; Tanaka S; Sakae K; Kimura T; Minagawa H; Miyazaki Y
Jpn J Infect Dis; 2007 Jul; 60(4):202-4. PubMed ID: 17642534
[TBL] [Abstract][Full Text] [Related]
28. [Effect of remantadine on the development of toxicoses caused by different strains of influenza virus].
Kiseleva IV
Vopr Virusol; 1981; (5):541-3. PubMed ID: 7336681
[TBL] [Abstract][Full Text] [Related]
29. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
[TBL] [Abstract][Full Text] [Related]
30. [The isolation and study of the properties of current influenza A viruses (H1N1) with a natural resistance to remantadine].
Kozeletskaia KN; Grinbaum EB; Zhamsrangiĭn M; Burmistrova VV; Kiselev OI
Vopr Virusol; 1990; 35(4):289-93. PubMed ID: 1701588
[TBL] [Abstract][Full Text] [Related]
31. Amino acid changes in the hemagglutinin and matrix proteins of influenza a (H2) viruses adapted to mice.
Govorkova EA; Gambaryan AS; Claas EC; Smirnov YA
Acta Virol; 2000 Oct; 44(5):241-8. PubMed ID: 11252668
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.
Heider H; Adamczyk B; Presber HW; Schroeder C; Feldblum R; Indulen MK
Acta Virol; 1981 Nov; 25(6):395-400. PubMed ID: 6120642
[TBL] [Abstract][Full Text] [Related]
33. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
Roberts PC; Lamb RA; Compans RW
Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697
[TBL] [Abstract][Full Text] [Related]
34. [Sensitivity to remantadine and other drugs of influenza A viruses isolated in 1982-1983].
Kozeletskaia KN; Medvedev ML; Golubev DB
Mikrobiol Zh (1978); 1986; 48(4):67-71. PubMed ID: 3271260
[No Abstract] [Full Text] [Related]
35. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).
Cox NJ; Kitame F; Kendal AP; Maassab HF; Naeve C
Virology; 1988 Dec; 167(2):554-67. PubMed ID: 2974219
[TBL] [Abstract][Full Text] [Related]
36. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
[TBL] [Abstract][Full Text] [Related]
37. [Pathology of the reproductive apparatus of cells under the action of remantadine and deitiforin].
Votiakov VI; Erokhina IR; Amvros'eva TV; Rusiaev VA
Biull Eksp Biol Med; 1989 Sep; 108(9):356-8. PubMed ID: 2611400
[TBL] [Abstract][Full Text] [Related]
38. [Resistance to amantadine of epidemic strain of H3 subtype influenza virus: a primary study].
Xu H; Qian Y; Xu H; Zhang JH; Zhu RN; Wang F
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):996-8. PubMed ID: 16759544
[TBL] [Abstract][Full Text] [Related]
39. Frequency of amantadine-resistant influenza A virus isolated from 2001-02 to 2004-05 in Nara Prefecture.
Kitahori Y; Nakano M; Inoue Y
Jpn J Infect Dis; 2006 Jun; 59(3):197-9. PubMed ID: 16785705
[TBL] [Abstract][Full Text] [Related]
40. [Effect of remantadine and amantadine on the interaction of influenza virus proteins with model lipid membranes].
Kharitonenkov IG; El Karadaghi S; Fedorov AN; Zakomyrdin IuA; Tverdislov VA
Vopr Virusol; 1988; 33(1):22-6. PubMed ID: 3369145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
